Vimarsana
Biggest News Aggregation in the World

Page 3 - Sarah Singleton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarah Singleton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarah Singleton Today - Breaking & Trending Today

Plans revealed to create Cumbrian cider mill - cumbriacrack.com - Vimarsana News

Plans revealed to create Cumbrian cider mill - cumbriacrack.com

Plans for an apple orchard and artisan cider mill in a Cumbrian town have been revealed.

Permission sought for apple orchard and cider mill - Vimarsana News

Permission sought for apple orchard and cider mill

AN APPLICATION seeking outline planning permission for an apple orchard and artisan cider mill in a Cumbria town has been submitted.

Wilhelmina Yazzie named New Mexico Woman of the Year - Vimarsana News

Wilhelmina Yazzie named New Mexico Woman of the Year

Wilhelmina Yazzie is a mother who saw her child struggling in school and took action.

ImmunityBio to Present 'Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15R⍺Fc superagonist N-803 plus BCG' at ASCO GU - Vimarsana News

ImmunityBio to Present 'Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15R⍺Fc superagonist N-803 plus BCG' at ASCO GU

A positive difference in physical function in responders versus non-responders was notedThe study indicates a favorable risk/benefit ratio and quality of life following N-803 plus BCG is comparable to BCG aloneCULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy comp...

ImmunityBio Announces Execution of $50 Million Equity Financing with Multiple Institutional Investor - Vimarsana News

ImmunityBio Announces Execution of $50 Million Equity Financing with Multiple Institutional Investor

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The Company entered into a securities purchase agreement for a registered dire...